active glp 1 Enrolling trial: GLP-1 agonist therapy in cystic fibrosis Plasma total glucagon-like peptide-1 (GLP-1,
Description
Study finds that individuals who took GLP-1 agonists for a long duration had a lower risk of going on to develop more severe forms of liver disease, including cirrhosis and liver cancer.
GLP-1 Probiotic+ Benefits: Digestive Support: Clostridium butyricum may help maintain balance in the digestive system
Wegovy is a more effective weight-loss jab than Trulicity
Subgroup analysis for treatment durations6 months indicated a higher WL in the GLP-1RAs group (SMD=0.79, 95% CI 0.25 to 1.34)
